PNPLA3 and metabolic syndrome: Furthermore, considering the importance of PNPLA3 polymorphisms in the etiology of NAFLD and, more crucially, HCC, genetic testing of particular groups, such as individuals with NAFLD but no metabolic syndrome symptoms, may be prudent [45].